chronic kidney disease
Oak Street Health centers in 21 states will leverage Strive's technology platform and services to help manage care for patients with chronic kidney disease.
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](/sites/mhn/files/styles/230x130/public/2025-07/%2528Left%2529%2520Ed%2520Deng%252C%2520Co-founder%2520and%2520CEO%2520of%2520Health2Sync%2520and%2520%2528Right%2529%2520Claudio%2520Longo%252C%2520President%2520of%2520AstraZeneca%2520Taiwan.jpg?itok=XO7M1UnC)
Health2Sync has upgraded its patient management platform to identify patients' CKD risk levels.
This marks the urinalysis and wound-care company's third 510(k) clearance.
Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images.
Healthy.io, a healthtech venture that already has offices in Israel, the UK, and the US, is expanding operations across MENA via a new partnership with the UAE’s Seed Group.
The website has been launched across 10 countries and in nine different languages.
The Nashville-based company partners with health plans to offer their members a range of renal care services.
The partnership with the Joslin Diabetes Center will add a panel of novel biomarkers to the indicators currently captured by KidneyIntelX.
Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.